PanPath
- Company typePrivate
- Founded2002
- HeadquartersBudel, Netherlands
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
PanPath firmographics
Firmographics- Name
- PanPath
- Legal name
- PanPath B.V.
- Website
- https://panpath.nl
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
PanPath industry classification
Industry- Product category
- Molecular Diagnostics / In Vitro Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)
- akta.pro secondary industries
- Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)
Keywords
Where PanPath is headquartered
LocationHeadquarters
- HQ city
- Budel
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
PanPath business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- Diagnostic Products: Sale of in vitro diagnostic products including FISH/ISH detection assay kits, stand-alone probes, and supporting products. Products available as IVD (In Vitro Diagnostics) or RUO (Research Use Only) variants.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | B2B pricing for diagnostic products |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
PanPath product offering
Product offeringCore offering
PanPath B.V. manufactures and sells the REMBRANDT® product line of FISH (Fluorescence In Situ Hybridization) and ISH (In Situ Hybridization) detection assay kits for molecular diagnostics. The portfolio covers chromosomal enumeration probes, locus-specific identifiers, gene amplification assays (HER2, MDM2, EGFR, TERC, SOX2), genetic rearrangement break-apart assays, chromosomal imbalance and microdeletion syndrome detection, prenatal enumeration, plus infectious disease assays (HPV, EBV/EBER), sold as IVD or RUO kits through a worldwide distributor network.
Product overview
PanPath B.V. is a diagnostic products company founded in 2002 and based in Budel, The Netherlands, offering the REMBRANDT® product family as a comprehensive diagnostic portfolio for the pathology market. The core offering consists of FISH (Fluorescence In Situ Hybridization) and ISH (In Situ Hybridization) detection assays designed for cancer-related genetic marker detection. The product range includes: infectious disease assays (HPV screening/typing and EBV/EBER detection), chromosomal enumeration probes (CEP1-18, X, Y), locus-specific identifiers (LSI) targeting specific genomic regions, gene amplification detection assays (HER2, TERC, SOX2, MDM2, EGFR), genetic rearrangement break-apart assays (THADA, RET, PLAG1, HMGA1/2, PPARγ, ZNF331/RITA), chromosomal imbalance detection assays, and microdeletion syndrome detection assays (Kallmann, Prader-Willi/Angelman, DiGeorge II). Supporting products include antibodies, reagents, pre-treatment kits, and laboratory consumables. The company also offers customized (F)ISH assay design services for specific research needs. Products are available as complete IVD/RUO kits or stand-alone probe mixes, with multiple detection formats (FISH, ISH, CISH, RISH, DISH) and labeling options (biotin, digoxigenin, fluorescent dyes).
Differentiator
Problem solved
Functional benefit
Brands
- REMBRANDT: Primary product brand for diagnostic FISH and ISH detection assays, including chromosomal enumeration probes, locus-specific identifiers, gene amplifications, and infectious disease detection assays
Products and services
- REMBRANDT® FISH Detection Assays Fluorescence In Situ Hybridization detection assays for enumerating chromosomes, detecting gene amplifications, genetic rearrangements, and chromosomal imbalances in formalin-fixed paraffin-embedded tissue sections or fixed cytological specimens, used by clinical pathology laboratories.
- REMBRANDT® ISH Detection Assays In Situ Hybridization detection assays using biotin or digoxigenin labeling for chromosomal and genetic analysis, available in multiple detection formats (BIO-AP, BIO-HRP, DIG-AP, DIG-HRP) for clinical pathology use.
- REMBRANDT® HPV Detection Assays
Companies that use PanPath
Customer profileNamed customers4 records
Segments2 records
Ideal customer profiles2 records
PanPath technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
PanPath partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered major, core and regional.
- NZOZ GENOS (Poland)majorMedical laboratory specializing in clinical genetics based in Lodz, Poland. Partnership established in 2006. GENOS serves as PanPath's distributor in Poland and also conducts performance studies for PanPath products. PanPath visited GENOS in 2023 for marketing strategy discussions on FISH products.
- Maastricht University Medical Centre (MUMC) - Division Molecular Cell BiologycorePartnership established in 2012. MUMC's MOLCELB division serves as a supporting partner in product development for PanPath B.V.
- Maastricht University Medical Centre (MUMC) - Division PathologycorePanPath works with the pathology division at MUMC for execution of clinical performance studies required for in vitro diagnostic regulation (IVDR) compliance.
- XboXLab ABregionalNew distributor appointed in February 2023 for Sweden, Finland, and Norway. Products available at xboxlab.se.
- BIOZOL Diagnostica Vertrieb GmbHregionalNew distributor appointed in February 2023 for Germany. Products available at biozol.de.
- Bio Medical Scientific Services LLC (Biomss)regionalNew distributor appointed in March 2023 for the United Arab Emirates. Products available at biomss.com.
- CliniSciences GroupmajorPanPath distributor covering multiple European countries: Belgium, France, Iceland, Luxembourg, and Netherlands. Major distributor partner with offices across Europe.
- Thermo Fisher Scientific (USA)majorMajor global distributor partner for PanPath products in the United States market.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
PanPath competitors and assessment
Company assessmentDirect peers
- Empire Genomics: US-based FISH probe manufacturer offering customized and catalog FISH probes for cancer and genetic disorder diagnostics. Competes directly with PanPath's customized assay offering and overall FISH probe portfolio.
- MetaSystems: Germany-based company offering FISH probes together with automated imaging and analysis platforms. Overlaps with PanPath's FISH probe business while also providing complementary hardware and software solutions to the same pathology lab customers.
- Cytocell (Revvity): UK-origin FISH probe manufacturer (now part of Revvity) specializing in IVD FISH probes for oncology and constitutional genetics. Direct competitor in the same FISH probe product category, serving similar pathology lab customers.
- Abnova Corporation: Taiwan-based developer and manufacturer of FISH probes, antibodies, and IVD reagents for clinical and research applications. Comparable in offering FISH probe products to pathology and cytogenetic labs globally.
- ZytoVision GmbH: German-based FISH probe manufacturer offering break-apart, amplification, and deletion FISH probes for cancer diagnostics. Direct competitor to PanPath in IVD FISH probe kits with similar product categories, customer base, and European distribution model.
- Vitro Master Diagnostics: Spanish IVD manufacturer of FISH probes for cancer diagnostics, including HER2, ALK, and ROS1 assays. Small specialty FISH vendor with similar business model and customer segments as PanPath.
- Kreatech Diagnostics (Leica Biosystems/Danaher): Originally a Dutch FISH probe company now part of Leica Biosystems, offering FISH probes for HER2, ALK, ROS1 and other oncology targets. Historical Dutch origin and overlapping FISH product portfolio make it a notable comparable to PanPath.
Broad incumbents
- Agilent Technologies (Dako): Through its Dako Pathology Solutions business, Agilent offers ISH probes and automated staining platforms for HER2 and other targets. Serves the same pathology lab customers with broader portfolio reach than PanPath.
- Abbott Molecular: Large diagnostics division offering FISH probes (Vysis product line) for HER2, ALK, ROS1, and other oncology targets as part of a broader molecular diagnostics portfolio. Competes with PanPath but also partners via distribution and serves a much wider diagnostic menu.
- Roche Diagnostics: Global diagnostics leader offering ISH and CISH products (including INFORM HER2) alongside its broader tissue diagnostics and molecular pathology business. A dominant incumbent in FISH/ISH that competes with PanPath on the same oncology assays.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
PanPath social profiles
Digital presencePanPath compliance and trust
Trust signalCompliance1 record
PanPath financial estimates
Financial estimateRevenue estimate
Valuation estimate
PanPath leadership team
Management profileNumber of profiles
Profiles1 record
PanPath funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PanPath M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PanPath
What does PanPath do?
PanPath B.V. manufactures and sells the REMBRANDT® product line of FISH (Fluorescence In Situ Hybridization) and ISH (In Situ Hybridization) detection assay kits for molecular diagnostics. The portfolio covers chromosomal enumeration probes, locus-specific identifiers, gene amplification assays (HER2, MDM2, EGFR, TERC, SOX2), genetic rearrangement break-apart assays, chromosomal imbalance and microdeletion syndrome detection, prenatal enumeration, plus infectious disease assays (HPV, EBV/EBER), sold as IVD or RUO kits through a worldwide distributor network.
Is PanPath a public or private company?
PanPath is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PanPath founded?
PanPath was founded in 2002. It employs 1 to 10 people.
Where is PanPath based?
PanPath is headquartered in Budel, Netherlands, in the Europe region.
How does PanPath make money?
One revenue line is on record: diagnostic Products.
Who are PanPath's main competitors?
Direct peers on record are Empire Genomics, MetaSystems, Cytocell (Revvity), Abnova Corporation, ZytoVision GmbH, Vitro Master Diagnostics and Kreatech Diagnostics (Leica Biosystems/Danaher). Broad incumbents are Agilent Technologies (Dako), Abbott Molecular and Roche Diagnostics.
Does PanPath have an API?
No public API is recorded for PanPath.
What industry is PanPath in?
PanPath's product category is Molecular Diagnostics / In Vitro Diagnostics. Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAHAAAI, Genetic, Cytogenetic & Prenatal Screening IVD. Its NAICS code is 325413 and its SIC code is 2835.